Skip to main navigation menu Skip to main content Skip to site footer

Review article: Biomedical intelligence

Vol. 149 No. 4142 (2019)

Biomarkers in cardiovascular medicine: towards precision medicine

DOI
https://doi.org/10.4414/smw.2019.20125
Cite this as:
Swiss Med Wkly. 2019;149:w20125
Published
07.10.2019

Abstract

Biomarkers are noninvasive, inexpensive, highly reproducible tools that allow clinicians to quantify pathophysiological processes relevant to a specific disease. Although the concept of biomarker-guided precision medicine is still in its infancy once a specific cardiovascular diagnosis is established, biomarker guidance has become the standard of care in the early diagnosis of acute cardiovascular disease in patients presenting to the emergency department with common symptoms such as acute chest pain or acute dyspnoea. This review highlights recent advances and remaining uncertainties regarding the use of the most relevant cardiovascular biomarkers, namely high-sensitivity cardiac troponin and natriuretic peptides in established indications such as the early diagnosis of acute myocardial infarction and heart failure. In addition, we address emerging indications such as the screening for perioperative myocardial infarction.

References

  1. Blomkalns AL, Gibler WB. Chest pain unit concept: rationale and diagnostic strategies. Cardiol Clin. 2005;23(4):411–21, v. doi:.https://doi.org/10.1016/j.ccl.2005.08.011
  2. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al.; ESC Scientific Document Group. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40(3):237–69. doi:.https://doi.org/10.1093/eurheartj/ehy462
  3. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al.; ESC Scientific Document Group. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267–315. doi:.https://doi.org/10.1093/eurheartj/ehv320
  4. Twerenbold R, Boeddinghaus J, Nestelberger T, Wildi K, Rubini Gimenez M, Badertscher P, et al. Clinical Use of High-Sensitivity Cardiac Troponin in Patients With Suspected Myocardial Infarction. J Am Coll Cardiol. 2017;70(8):996–1012. doi:.https://doi.org/10.1016/j.jacc.2017.07.718
  5. Twerenbold R, Boeddinghaus J, Mueller C. Update on High-sensitivity cardiac troponin in patients with suspected myocardial infarction. Eur Heart J Suppl. 2018;20(suppl_G):G2–10. doi:.https://doi.org/10.1093/eurheartj/suy020
  6. Twerenbold R, Boeddinghaus J, Nestelberger T, Wildi K, Rubini Gimenez M, Badertscher P, et al. How to best use high-sensitivity cardiac troponin in patients with suspected myocardial infarction. Clin Biochem. 2018;53:143–55. doi:.https://doi.org/10.1016/j.clinbiochem.2017.12.006
  7. Thygesen K, Mair J, Katus H, Plebani M, Venge P, Collinson P, et al.; Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J. 2010;31(18):2197–204. doi:.https://doi.org/10.1093/eurheartj/ehq251
  8. Thygesen K, Mair J, Giannitsis E, Mueller C, Lindahl B, Blankenberg S, et al.; Study Group on Biomarkers in Cardiology of ESC Working Group on Acute Cardiac Care. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J. 2012;33(18):2252–7. doi:.https://doi.org/10.1093/eurheartj/ehs154
  9. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009;361(9):858–67. doi:.https://doi.org/10.1056/NEJMoa0900428
  10. Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med. 2009;361(9):868–77. doi:.https://doi.org/10.1056/NEJMoa0903515
  11. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2010;56(2):254–61. doi:.https://doi.org/10.1373/clinchem.2009.132654
  12. Haaf P, Drexler B, Reichlin T, Twerenbold R, Reiter M, Meissner J, et al. High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease. Circulation. 2012;126(1):31–40. doi:.https://doi.org/10.1161/CIRCULATIONAHA.112.100867
  13. Reiter M, Twerenbold R, Reichlin T, Haaf P, Peter F, Meissner J, et al. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J. 2011;32(11):1379–89. doi:.https://doi.org/10.1093/eurheartj/ehr033
  14. Reiter M, Twerenbold R, Reichlin T, Benz B, Haaf P, Meissner J, et al. Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays. Eur Heart J. 2012;33(8):988–97. doi:.https://doi.org/10.1093/eurheartj/ehr376
  15. Apple FS. A new season for cardiac troponin assays: it’s time to keep a scorecard. Clin Chem. 2009;55(7):1303–6. doi:.https://doi.org/10.1373/clinchem.2009.128363
  16. Rubini Gimenez M, Twerenbold R, Reichlin T, Wildi K, Haaf P, Schaefer M, et al. Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction. Eur Heart J. 2014;35(34):2303–11. doi:.https://doi.org/10.1093/eurheartj/ehu188
  17. Meune C, Reichlin T, Irfan A, Schaub N, Twerenbold R, Meissner J, et al. How safe is the outpatient management of patients with acute chest pain and mildly increased cardiac troponin concentrations? Clin Chem. 2012;58(5):916–24. doi:.https://doi.org/10.1373/clinchem.2011.178053
  18. Reichlin T, Cullen L, Parsonage WA, Greenslade J, Twerenbold R, Moehring B, et al. Two-hour algorithm for triage toward rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Am J Med. 2015;128(4):369–79.e4. doi:.https://doi.org/10.1016/j.amjmed.2014.10.032
  19. Reichlin T, Irfan A, Twerenbold R, Reiter M, Hochholzer W, Burkhalter H, et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation. 2011;124(2):136–45. doi:.https://doi.org/10.1161/CIRCULATIONAHA.111.023937
  20. Reichlin T, Schindler C, Drexler B, Twerenbold R, Reiter M, Zellweger C, et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med. 2012;172(16):1211–8. doi:.https://doi.org/10.1001/archinternmed.2012.3698
  21. Mueller M, Biener M, Vafaie M, Doerr S, Keller T, Blankenberg S, et al. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin Chem. 2012;58(1):209–18. doi:.https://doi.org/10.1373/clinchem.2011.171827
  22. Mueller C. Biomarkers and acute coronary syndromes: an update. Eur Heart J. 2014;35(9):552–6. doi:.https://doi.org/10.1093/eurheartj/eht530
  23. Than M, Cullen L, Reid CM, Lim SH, Aldous S, Ardagh MW, et al. A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study. Lancet. 2011;377(9771):1077–84. doi:.https://doi.org/10.1016/S0140-6736(11)60310-3
  24. Than M, Cullen L, Aldous S, Parsonage WA, Reid CM, Greenslade J, et al. 2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial. J Am Coll Cardiol. 2012;59(23):2091–8. doi:.https://doi.org/10.1016/j.jacc.2012.02.035
  25. Cullen L, Mueller C, Parsonage WA, Wildi K, Greenslade JH, Twerenbold R, et al. Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol. 2013;62(14):1242–9. doi:.https://doi.org/10.1016/j.jacc.2013.02.078
  26. Than M, Aldous S, Lord SJ, Goodacre S, Frampton CM, Troughton R, et al. A 2-hour diagnostic protocol for possible cardiac chest pain in the emergency department: a randomized clinical trial. JAMA Intern Med. 2014;174(1):51–8. doi:.https://doi.org/10.1001/jamainternmed.2013.11362
  27. Meller B, Cullen L, Parsonage WA, Greenslade JH, Aldous S, Reichlin T, et al. Accelerated diagnostic protocol using high-sensitivity cardiac troponin T in acute chest pain patients. Int J Cardiol. 2015;184:208–15. doi:.https://doi.org/10.1016/j.ijcard.2015.02.006
  28. Hammarsten O, Fu ML, Sigurjonsdottir R, Petzold M, Said L, Landin-Wilhelmsen K, et al. Troponin T percentiles from a random population sample, emergency room patients and patients with myocardial infarction. Clin Chem. 2012;58(3):628–37. doi:.https://doi.org/10.1373/clinchem.2011.171496
  29. Reichlin T, Twerenbold R, Wildi K, Gimenez MR, Bergsma N, Haaf P, et al. Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assay. CMAJ. 2015;187(8):E243–52. doi:.https://doi.org/10.1503/cmaj.141349
  30. Rubini Gimenez M, Twerenbold R, Jaeger C, Schindler C, Puelacher C, Wildi K, et al. One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. Am J Med. 2015;128(8):861–870.e4. doi:.https://doi.org/10.1016/j.amjmed.2015.01.046
  31. Body R, Carley S, McDowell G, Jaffe AS, France M, Cruickshank K, et al. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J Am Coll Cardiol. 2011;58(13):1332–9. doi:.https://doi.org/10.1016/j.jacc.2011.06.026
  32. Rubini Giménez M, Hoeller R, Reichlin T, Zellweger C, Twerenbold R, Reiter M, et al. Rapid rule out of acute myocardial infarction using undetectable levels of high-sensitivity cardiac troponin. Int J Cardiol. 2013;168(4):3896–901. doi:.https://doi.org/10.1016/j.ijcard.2013.06.049
  33. Hollander JE, Than M, Mueller C. State-of-the-Art Evaluation of Emergency Department Patients Presenting With Potential Acute Coronary Syndromes. Circulation. 2016;134(7):547–64. doi:.https://doi.org/10.1161/CIRCULATIONAHA.116.021886
  34. Keller T, Zeller T, Ojeda F, Tzikas S, Lillpopp L, Sinning C, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA. 2011;306(24):2684–93. doi:.https://doi.org/10.1001/jama.2011.1896
  35. Twerenbold R, Rubini Gimenez M, Nestelberger T, Boeddinghaus J, Wildi K, Mueller C. Optimising the early rule-out and rule-in of myocardial infarction using biomarkers. Cardiovasc Med. 2019;22:w02010. doi:.https://doi.org/10.4414/cvm.2019.02010
  36. Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Jr, Ganiats TG, Holmes DR, Jr, et al. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64(24):e139–228. doi:. Correction in: J Am Coll Cardiol. 2014;64(24):2713–4. doi:https://doi.org/10.1016/j.jacc.2014.09.017
  37. Hollander JE. Managing Troponin Testing. Ann Emerg Med. 2016;68(6):690–4. doi:.https://doi.org/10.1016/j.annemergmed.2016.05.023
  38. Mair J, Lindahl B, Müller C, Giannitsis E, Huber K, Möckel M, et al. What to do when you question cardiac troponin values. Eur Heart J Acute Cardiovasc Care. 2018;7(6):577–86. doi:.https://doi.org/10.1177/2048872617708973
  39. Schmid J, Liesinger L, Birner-Gruenberger R, Stojakovic T, Scharnagl H, Dieplinger B, et al. Elevated Cardiac Troponin T in Patients With Skeletal Myopathies. J Am Coll Cardiol. 2018;71(14):1540–9. doi:.https://doi.org/10.1016/j.jacc.2018.01.070
  40. Badertscher P, Boeddinghaus J, Twerenbold R, Nestelberger T, Wildi K, Wussler D, et al.; APACE Investigators. Direct Comparison of the 0/1h and 0/3h Algorithms for Early Rule-Out of Acute Myocardial Infarction. Circulation. 2018;137(23):2536–8. doi:.https://doi.org/10.1161/CIRCULATIONAHA.118.034260
  41. Chapman AR, Anand A, Boeddinghaus J, Ferry AV, Sandeman D, Adamson PD, et al. Comparison of the Efficacy and Safety of Early Rule-Out Pathways for Acute Myocardial Infarction. Circulation. 2017;135(17):1586–96. doi:.https://doi.org/10.1161/CIRCULATIONAHA.116.025021
  42. Chapman AR, Hesse K, Andrews J, Ken Lee K, Anand A, Shah ASV, et al. High-Sensitivity Cardiac Troponin I and Clinical Risk Scores in Patients With Suspected Acute Coronary Syndrome. Circulation. 2018;138(16):1654–65. doi:.https://doi.org/10.1161/CIRCULATIONAHA.118.036426
  43. Twerenbold R, Costabel JP, Nestelberger T, Campos R, Wussler D, Arbucci R, et al. Outcome of Applying the ESC 0/1-hour Algorithm in Patients With Suspected Myocardial Infarction. J Am Coll Cardiol. 2019;74(4):483–94. doi: https://doi.org/10.1016/j.jacc.2019.05.046
  44. Mueller C, Giannitsis E, Christ M, Ordóñez-Llanos J, deFilippi C, McCord J, et al.; TRAPID-AMI Investigators. Multicenter Evaluation of a 0-Hour/1-Hour Algorithm in the Diagnosis of Myocardial Infarction With High-Sensitivity Cardiac Troponin T. Ann Emerg Med. 2016;68(1):76–87.e4. doi:.https://doi.org/10.1016/j.annemergmed.2015.11.013
  45. Twerenbold R, Neumann JT, Sörensen NA, Ojeda F, Karakas M, Boeddinghaus J, et al. Prospective Validation of the 0/1-h Algorithm for Early Diagnosis of Myocardial Infarction. J Am Coll Cardiol. 2018;72(6):620–32. doi:.https://doi.org/10.1016/j.jacc.2018.05.040
  46. Boeddinghaus J, Nestelberger T, Twerenbold R, Wildi K, Badertscher P, Cupa J, et al. Direct Comparison of 4 Very Early Rule-Out Strategies for Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin I. Circulation. 2017;135(17):1597–611. doi:.https://doi.org/10.1161/CIRCULATIONAHA.116.025661
  47. Twerenbold R, Wildi K, Jaeger C, Gimenez MR, Reiter M, Reichlin T, et al. Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction. Circulation. 2015;131(23):2041–50. doi:.https://doi.org/10.1161/CIRCULATIONAHA.114.014245
  48. Twerenbold R, Badertscher P, Boeddinghaus J, Nestelberger T, Wildi K, Puelacher C, et al. 0/1-Hour Triage Algorithm for Myocardial Infarction in Patients With Renal Dysfunction. Circulation. 2018;137(5):436–51. doi:.https://doi.org/10.1161/CIRCULATIONAHA.117.028901
  49. Boeddinghaus J, Nestelberger T, Twerenbold R, Neumann JT, Lindahl B, Giannitsis E, et al.; APACE, BACC, and TRAPID-AMI Investigators. Impact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarction. Eur Heart J. 2018;39(42):3780–94. doi:.https://doi.org/10.1093/eurheartj/ehy514
  50. Druey S, Wildi K, Twerenbold R, Jaeger C, Reichlin T, Haaf P, et al. Early rule-out and rule-in of myocardial infarction using sensitive cardiac Troponin I. Int J Cardiol. 2015;195:163–70. doi:.https://doi.org/10.1016/j.ijcard.2015.05.079
  51. Boeddinghaus J, Reichlin T, Cullen L, Greenslade JH, Parsonage WA, Hammett C, et al. Two-Hour Algorithm for Triage toward Rule-Out and Rule-In of Acute Myocardial Infarction by Use of High-Sensitivity Cardiac Troponin I. Clin Chem. 2016;62(3):494–504. doi:.https://doi.org/10.1373/clinchem.2015.249508
  52. Nestelberger T, Wildi K, Boeddinghaus J, Twerenbold R, Reichlin T, Giménez MR, et al. Characterization of the observe zone of the ESC 2015 high-sensitivity cardiac troponin 0h/1h-algorithm for the early diagnosis of acute myocardial infarction. Int J Cardiol. 2016;207:238–45. doi:.https://doi.org/10.1016/j.ijcard.2016.01.112
  53. Schlett CL, Hoffmann U, Geisler T, Nikolaou K, Bamberg F. Cardiac computed tomography for the evaluation of the acute chest pain syndrome: state of the art. Radiol Clin North Am. 2015;53(2):297–305. doi:.https://doi.org/10.1016/j.rcl.2014.11.007
  54. Dedic A, Lubbers MM, Schaap J, Lammers J, Lamfers EJ, Rensing BJ, et al. Coronary CT Angiography for Suspected ACS in the Era of High-Sensitivity Troponins: Randomized Multicenter Study. J Am Coll Cardiol. 2016;67(1):16–26. doi:.https://doi.org/10.1016/j.jacc.2015.10.045
  55. Weiser TG, Haynes AB, Molina G, Lipsitz SR, Esquivel MM, Uribe-Leitz T, et al. Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes. Lancet. 2015;385(Suppl 2):S11. doi:.https://doi.org/10.1016/S0140-6736(15)60806-6
  56. Pearse RM, Moreno RP, Bauer P, Pelosi P, Metnitz P, Spies C, et al.; European Surgical Outcomes Study (EuSOS) group for the Trials groups of the European Society of Intensive Care Medicine and the European Society of Anaesthesiology. Mortality after surgery in Europe: a 7 day cohort study. Lancet. 2012;380(9847):1059–65. doi:.https://doi.org/10.1016/S0140-6736(12)61148-9
  57. Devereaux PJ, Biccard BM, Sigamani A, Xavier D, Chan MTV, Srinathan SK, et al.; Writing Committee for the VISION Study Investigators. Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery. JAMA. 2017;317(16):1642–51. doi:.https://doi.org/10.1001/jama.2017.4360
  58. Puelacher C, Lurati Buse G, Seeberger D, Sazgary L, Marbot S, Lampart A, et al.; BASEL-PMI Investigators. Perioperative Myocardial Injury After Noncardiac Surgery: Incidence, Mortality, and Characterization. Circulation. 2018;137(12):1221–32. doi:.https://doi.org/10.1161/CIRCULATIONAHA.117.030114
  59. Puelacher C, Lurati-Buse G, Singeisen H, Dang M, Cuculi F, Müller C. Perioperative myocardial infarction/injury after noncardiac surgery. Swiss Med Wkly. 2015;145:w14219. doi:.https://doi.org/10.4414/smw.2015.14219
  60. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100(10):1043–9. doi:.https://doi.org/10.1161/01.CIR.100.10.1043
  61. Bilimoria KY, Liu Y, Paruch JL, Zhou L, Kmiecik TE, Ko CY, et al. Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg. 2013;217(5):833–42.e3. doi:.https://doi.org/10.1016/j.jamcollsurg.2013.07.385
  62. Gualandro DM, Puelacher C, LuratiBuse G, Llobet GB, Yu PC, Cardozo FA, et al.; GREAT network. Prediction of major cardiac events after vascular surgery. J Vasc Surg. 2017;66(6):1826–1835.e1. doi:.https://doi.org/10.1016/j.jvs.2017.05.100
  63. Rodseth RN, Biccard BM, Le Manach Y, Sessler DI, Lurati Buse GA, Thabane L, et al. The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis. J Am Coll Cardiol. 2014;63(2):170–80. doi:.https://doi.org/10.1016/j.jacc.2013.08.1630
  64. Gualandro DM, Puelacher C, LuratiBuse G, Lampart A, Strunz C, Cardozo FA, et al.; TropoVasc and BASEL-PMI Investigators. Comparison of high-sensitivity cardiac troponin I and T for the prediction of cardiac complications after non-cardiac surgery. Am Heart J. 2018;203:67–73. doi:.https://doi.org/10.1016/j.ahj.2018.06.012
  65. Nagele P, Brown F, Gage BF, Gibson DW, Miller JP, Jaffe AS, et al. High-sensitivity cardiac troponin T in prediction and diagnosis of myocardial infarction and long-term mortality after noncardiac surgery. Am Heart J. 2013;166(2):325–332.e1. doi:.https://doi.org/10.1016/j.ahj.2013.04.018
  66. Weber M, Luchner A, Seeberger M, Mueller C, Liebetrau C, Schlitt A, et al. Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratification in non-cardiac surgery. Eur Heart J. 2013;34(11):853–62. doi:.https://doi.org/10.1093/eurheartj/ehs445
  67. Gillmann HJ, Meinders A, Grohennig A, Larmann J, Bünte C, Calmer S, et al. Perioperative levels and changes of high-sensitivity troponin T are associated with cardiovascular events in vascular surgery patients. Crit Care Med. 2014;42(6):1498–506. doi:.https://doi.org/10.1097/CCM.0000000000000249
  68. Gualandro DM, Yu PC, Caramelli B, Marques AC, Calderaro D, Fornari LS, et al. 3rd Guideline for Perioperative Cardiovascular Evaluation of the Brazilian Society of Cardiology. Arq Bras Cardiol. 2017;109(3, Supl 1):1–104. doi:.https://doi.org/10.5935/abc.20170140
  69. Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker HE, Hert SD, et al., Authors/Task Force Members. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014;35(35):2383–431. doi:.https://doi.org/10.1093/eurheartj/ehu282
  70. Duceppe E, Parlow J, MacDonald P, Lyons K, McMullen M, Srinathan S, et al. Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery. Can J Cardiol. 2017;33(1):17–32. doi:.https://doi.org/10.1016/j.cjca.2016.09.008
  71. Kavsak PA, Walsh M, Srinathan S, Thorlacius L, Buse GL, Botto F, et al. High sensitivity troponin T concentrations in patients undergoing noncardiac surgery: a prospective cohort study. Clin Biochem. 2011;44(12):1021–4. doi:.https://doi.org/10.1016/j.clinbiochem.2011.05.017
  72. Noordzij PG, van Geffen O, Dijkstra IM, Boerma D, Meinders AJ, Rettig TC, et al. High-sensitive cardiac troponin T measurements in prediction of non-cardiac complications after major abdominal surgery. Br J Anaesth. 2015;114(6):909–18. doi:.https://doi.org/10.1093/bja/aev027
  73. Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, et al.; Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med. 2009;361(26):2538–47. doi:.https://doi.org/10.1056/NEJMoa0805299
  74. Jia X, Sun W, Hoogeveen RC, Nambi V, Matsushita K, Folsom AR, et al. High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study. Circulation. 2019;139(23):2642–53. doi:.https://doi.org/10.1161/CIRCULATIONAHA.118.038772
  75. Felker GM, Mentz RJ, Teerlink JR, Voors AA, Pang PS, Ponikowski P, et al. Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study. Eur J Heart Fail. 2015;17(12):1262–70. doi:.https://doi.org/10.1002/ejhf.341
  76. Cavender MA, White WB, Jarolim P, Bakris GL, Cushman WC, Kupfer S, et al. Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care). Circulation. 2017;135(20):1911–21. doi:.https://doi.org/10.1161/CIRCULATIONAHA.116.024632
  77. Gualandro DM, Campos CA, Calderaro D, Yu PC, Marques AC, Pastana AF, et al. Coronary plaque rupture in patients with myocardial infarction after noncardiac surgery: frequent and dangerous. Atherosclerosis. 2012;222(1):191–5. doi:.https://doi.org/10.1016/j.atherosclerosis.2012.02.021
  78. Gualandro DM, Puelacher C, Mueller C. High-sensitivity cardiac troponin in acute conditions. Curr Opin Crit Care. 2014;20(5):472–7. doi:.https://doi.org/10.1097/MCC.0000000000000132
  79. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al.; ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–200. doi:.https://doi.org/10.1093/eurheartj/ehw128
  80. Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Jr, Ganiats TG, Holmes DR, Jr, et al.; ACC/AHA Task Force Members. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130(25):e344–426.. Correction in: Circulation. 2014;130(25):e433–4.
  81. Kozhuharov N, Sabti Z, Wussler D, Nowak A, Badertscher P, Twerenbold R, et al.; BASEL V Investigators. Prospective validation of N-terminal pro B-type natriuretic peptide cut-off concentrations for the diagnosis of acute heart failure. Eur J Heart Fail. 2019;21(6):813–5. doi:.https://doi.org/10.1002/ejhf.1471
  82. Seferović PM, Polovina M, Bauersachs J, Arad M, Gal TB, Lund LH, et al. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019;21(5):553–76. doi:.https://doi.org/10.1002/ejhf.1461
  83. Mueller C, Buser P. B-type natriuretic peptide (BNP): can it improve our management of patients with congestive heart failure? Swiss Med Wkly. 2002;132(43-44):618–22.
  84. Hammill BG, Curtis LH, Bennett-Guerrero E, O’Connor CM, Jollis JG, Schulman KA, et al. Impact of heart failure on patients undergoing major noncardiac surgery. Anesthesiology. 2008;108(4):559–67. doi:.https://doi.org/10.1097/ALN.0b013e31816725ef
  85. Healy KO, Waksmonski CA, Altman RK, Stetson PD, Reyentovich A, Maurer MS. Perioperative outcome and long-term mortality for heart failure patients undergoing intermediate- and high-risk noncardiac surgery: impact of left ventricular ejection fraction. Congest Heart Fail. 2010;16(2):45–9. doi:.https://doi.org/10.1111/j.1751-7133.2009.00130.x
  86. Fayad A, Ansari MT, Yang H, Ruddy T, Wells GA. Perioperative Diastolic Dysfunction in Patients Undergoing Noncardiac Surgery Is an Independent Risk Factor for Cardiovascular Events: A Systematic Review and Meta-analysis. Anesthesiology. 2016;125(1):72–91. doi:.https://doi.org/10.1097/ALN.0000000000001132
  87. Karthikeyan G, Moncur RA, Levine O, Heels-Ansdell D, Chan MT, Alonso-Coello P, et al. Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J Am Coll Cardiol. 2009;54(17):1599–606. doi:.https://doi.org/10.1016/j.jacc.2009.06.028
  88. Ryding AD, Kumar S, Worthington AM, Burgess D. Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis. Anesthesiology. 2009;111(2):311–9. doi:.https://doi.org/10.1097/ALN.0b013e3181aaeb11
  89. Rodseth RN, Lurati Buse GA, Bolliger D, Burkhart CS, Cuthbertson BH, Gibson SC, et al. The predictive ability of pre-operative B-type natriuretic peptide in vascular patients for major adverse cardiac events: an individual patient data meta-analysis. J Am Coll Cardiol. 2011;58(5):522–9. doi:.https://doi.org/10.1016/j.jacc.2011.04.018
  90. Kopec M, Duma A, Helwani MA, Brown J, Brown F, Gage BF, et al. Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP. Anesth Analg. 2017;124(2):398–405. doi:.https://doi.org/10.1213/ANE.0000000000001736
  91. Biccard BM, Naidoo P. The role of brain natriuretic peptide in prognostication and reclassification of risk in patients undergoing vascular surgery. Anaesthesia. 2011;66(5):379–85. doi:.https://doi.org/10.1111/j.1365-2044.2011.06694.x
  92. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al.; ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–200. doi:.https://doi.org/10.1093/eurheartj/ehw128
  93. van Vark LC, Lesman-Leegte I, Baart SJ, Postmus D, Pinto YM, Orsel JG, et al.; TRIUMPH Investigators. Prognostic Value of Serial ST2 Measurements in Patients With Acute Heart Failure. J Am Coll Cardiol. 2017;70(19):2378–88. doi:.https://doi.org/10.1016/j.jacc.2017.09.026
  94. Yang HS, Hur M, Yi A, Kim H, Kim J. Prognostic Role of High-sensitivity Cardiac Troponin I and Soluble Suppression of Tumorigenicity-2 in Surgical Intensive Care Unit Patients Undergoing Non-cardiac Surgery. Ann Lab Med. 2018;38(3):204–11. doi:.https://doi.org/10.3343/alm.2018.38.3.204
  95. Jarai R, Mahla E, Perkmann T, Jarai R, Archan S, Tentzeris I, et al. Usefulness of pre-operative copeptin concentrations to predict post-operative outcome after major vascular surgery. Am J Cardiol. 2011;108(8):1188–95. doi:.https://doi.org/10.1016/j.amjcard.2011.06.024
  96. Gu Z, Sun C, Xiang D. Postoperative Adverse Cardiovascular Events Associated with Leptin and Adverse Age After Elective Major Non-Cardiac Surgery: An Asian Single-Center Study. Med Sci Monit. 2018;24:2119–25. doi:.https://doi.org/10.12659/MSM.906797
  97. Marković D, Jevtović-Stoimenov T, Ćosić V, Stošić B, Dinić V, Marković-Živković B, et al. Clinical Utility of Survivin (BIRC5), Novel Cardiac Biomarker, as a Prognostic Tool Compared to High-sensitivity C-reactive Protein, Heart-type Fatty Acid Binding Protein and Revised Lee Score in Elderly Patients Scheduled for Major Non-cardiac Surgery: A Prospective Pilot Study. J Med Biochem. 2018;37(2):110–20. doi:.https://doi.org/10.1515/jomb-2017-0046
  98. Golubović M, Janković R, Sokolović D, Ćosić V, Maravić-Stojkovic V, Kostić T, et al. Preoperative Midregional Pro-Adrenomedullin and High-Sensitivity Troponin T Predict Perioperative Cardiovascular Events in Noncardiac Surgery. Med Princ Pract. 2018;27(3):278–84. doi:.https://doi.org/10.1159/000488197
  99. Gillmann HJ, Meinders A, Larmann J, Sahlmann B, Schrimpf C, Aper T, et al. Adrenomedullin Is Associated With Surgical Trauma and Impaired Renal Function in Vascular Surgery Patients. J Intensive Care Med. 2019;34(1):67–76. doi:.https://doi.org/10.1177/0885066616689554

Most read articles by the same author(s)

1 2 > >>